| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 4.03 | 0.05 (+1.26%) | 1.60 - 5.22 | 456.0 (Below Avg) |
Market data as of 9:49AM 06/19/13. Quotes are delayed by at least 15 min.
Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Cancer Preclinical Models with Addition of Galectin Inhibitor
06/12/2013 8:00 AM ET
Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders -- New Phone Number for Audio Portion of Presentation
05/23/2013 9:16 AM ET
Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders
05/15/2013 8:00 AM ET